Minoryx spins off therapeutic platform to identify next-gen pharmacological chaperones

Clinical stage biotech company, Minoryx Therapeutics, has revealed it is spinning off its Site-directed Enzyme Enhancement Therapy (SEE-Tx) platform into a new company, Gain Therapeutics more

20 Feb 2018 14:10 Technology